Novel Arylalkenylpropargylamines as Neuroprotective, Potent, and Selective Monoamine Oxidase B Inhibitors for the Treatment of Parkinson’s Disease (2015)Paul B. Huleatt, Mui Ling Khoo, Yi Yuan Chua, Tiong Wei Tan, Rou Shen Liew, Balázs Balogh, Ruth Deme, Flóra Gölöncsér, Kalman Magyar, David P. Sheela, Han Kiat Ho, Beáta Sperlágh, Péter Mátyus, Christina L. L. Chai Journal of Medicinal Chemistry 58/3 p1400-1419
American Chemical Society (ACS) DOI:10.1021/jm501722s